lifestyle.social-matic.com

Author: Telix Pharmaceuticals Limited

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

February 19, 2026
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

February 17, 2026
Telix Full Year Results 2025 Investor Webcast Notification

February 10, 2026
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

January 20, 2026